Por: ABC7 Health March 11, 2023
The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) - the first and only migraine treatment of its kind to be offered in nasal spray.The drug has shown in clinical trial data to provide rapid pain relief in as fast as 15 minutes for migraine sufferers, with relief lasting up to 48 hours, Pfizer said.Migraines are one of the most common debilitating medical conditions, said... + full article
ABC7 USA Health March 11, 2023
The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) - the first and only migraine treatment of its kind to be offered in nasal spray.The drug has shown in clinical trial data to provide rapid pain relief in... + más
FDA approves Prizer's Zavzpret, first of its kind migraine treatment nasal spray | ABC7
FDA approves Pfizer's new nasal spray treatment for migraines | ABC News
ABC News USA Health March 11, 2023
The U.S. Food and Drug Administration has approved Pfizer's newest drug on the market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.The drug has shown in clinical trial data to provide rapid pain relief in as fast... + más
F.D.A. Approves New Nasal Spray for Migraines | The New York Times
FDA Approves a New Nasal Spray to Treat Migraines | Time
The New York Times USA Health March 11, 2023
The Food and Drug Administration has approved a Pfizer nasal spray for treatment of migraines that uses a different therapy from other nasal products on the market for severe headache pain, the company said on Friday.The fast-acting treatment, which is called zavegepant and will... + más
New York Daily News USA Health March 11, 2023
The U.S. Food and Drug Administration has approved a nasal spray developed by Pfizer as a means to quickly treat the painful symptoms associated with suffering a migraine. The drug, Zavzpret, also known as zavegepant, was approved on Thursday for the treatment of acute migraines... + más
WPTV USA Nation March 11, 2023
People who suffer from migraines will have another option to get relief. The Food and Drug Administration approved Pfizer's Zavzpret this week. Pfizer says it's the first nasal spray approved to block calcitonin gene-related peptide, a protein believed to contribute... + más
Time USA Health March 10, 2023
On Mar. 10, the U.S. Food and Drug Administration (FDA) a new treatment for migraines given as a nasal spray, according to the drug’s maker, Pfizer. Zavegepant (brand name: Zavzpret), is the first of a class of migraine treatments known as calcitonin gene-related peptide... + más
CBS News USA Health March 10, 2023
Pfizer said Friday that the Food and Drug Administration has approved a new nasal spray to treat migraines.Zavzpret, a branded formulation of the generic drug zavegepant, is the first and only calcitonin gene-related peptide receptor antagonist nasal spray for treating... + más
About iurex | Privacy Policy | Disclaimer |